|
|
|
| Influence of Pharmaceutical Care Led by Clinical Pharmacists on Rationality of Chinese Patent Medicines for Promoting Blood Circulation and Removing Blood Stasis |
| Liu Jun, Yuan Yuzhe, Zhang Jigui |
| Pharmacy Department of Nanyang Traditional Chinese Medicine Hospital,Henan 473000,China |
|
|
|
|
Abstract Objective To explore the influence of clinical pharmacist led pharmaceutical care on the rationality of the use of Chinese patent medicines for promoting blood circulation and removing blood stasis.Methods 480 patients treated with Chinese patent medicine for promoting blood circulation and removing blood stasis were selected as the research objects,and they were randomly divided into observation group and control group with 240 cases in each group.The observation group was given pharmaceutical care led by clinical pharmacists,while the control group was given routine pharmaceutical care.Before and after the intervention,the rational drug use,drug understanding,drug compliance and satisfaction of the two groups were compared.Results the rate of irrational drug use in the observation group was 28.33%,which was significantly lower than that in the control group（45.42%）（P<0.05）;Before the intervention led by clinical pharmacists,There was no significant difference in drug understanding and drug compliance between the two groups（P>0.05）.After the intervention,the drug understanding and drug compliance of the two groups were higher than those before the intervention,and the wide intervention was significantly higher than that of the control group（P<0.05）;After the intervention led by clinical pharmacists,the total satisfaction of the observation group was 93.33%,which was significantly higher than that of the control group（82.50%）（P<0.05）;After clinical pharmacist led intervention,the incidence of adverse reactions in the observation group（12.08%）was significantly lower than that in the control group（19.17%）（P<0.05）.Conclusion Chinese medicine can improve the rationality of Chinese medicine.
|
|
Received: 07 July 2022
|
|
|
|
|
|
[1] 江华,曹磊磊.2016年启东市人民医院活血化瘀类中成药的使用情况分析[J].现代药物与临床,2017,32(9):1780-1784.
[2] 黄玉普,李希,黄嫣,等.临床药师参与活血化瘀类中药注射剂临床应用管理的实践[J].药学服务与研究,2020,20(3):202-205.
[3] 李燕. 某院2013年至2015年中药注射剂应用分析[J].中国药业,2017,26(4):88-91.
[4] 佚名. 医疗机构药事管理规定[J].药物不良反应杂志,2011,13(2):105-108.
[5] 薛胜霞,张国忠,刘辉,等.临床药师在痛风管理中工作模式与效果评价的探讨[J].中国医院药学杂志,2021,41(10):1064-1068.
[6] 许越,卢家明,王静,等.基于消费者视角的成都市社会药房电子处方及远程药学服务实施现状和效果的调查分析[J].中国药房,2021,32(4):398-405.
[7] 景少博,张建平,李建国,等.基于中医瘀血理论探讨骨质疏松症中医发病机制认识及治疗进展[J].中国骨质疏松杂志,2021,27(2):275-278.
[8] Huang L,Xu R,Huang X,et al.Traditional Chinese medicine injection for promoting blood circulation and removing blood stasis in treating angina pectoris of coronary heart disease:A protocol for systematic review and network meta-analysis[J].Medicine(Baltimore).2021,100(16):e25608.
[9] 杨椰,黄必德.合理用药干预前后活血化瘀类中药注射剂应用合理性分析及干预效果探讨[J].中国医院用药评价与分析,2019,19(3):373-374,377.
[10] 陈文衍,蔡卫民,马国.患者及其家属对临床药师与药学服务认知和需求情况调查研究[J].中国医院药学杂志,2017,37(24):2490-2495. |
|
|
|
2023, Vol. 43 
